Discontinued — last reported Q4 '26
Best Buy Total Cost of Revenue increased by 47.3% to $10.93B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 0.9%, from $11.03B to $10.93B. Over 4 years (FY 2022 to FY 2026), Total Cost of Revenue shows a downward trend with a -5.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.92B | $9.04B | $9.11B | $13.05B | $8.29B | $8.04B | $8.26B | $11.80B | $7.32B | $7.36B | $7.52B | $11.65B | $6.78B | $7.10B | $7.23B | $11.03B | $6.72B | $7.24B | $7.42B | $10.93B |
| QoQ Change | — | +1.3% | +0.8% | +43.3% | -36.5% | -3.0% | +2.6% | +42.9% | -38.0% | +0.6% | +2.2% | +54.8% | -41.8% | +4.7% | +1.8% | +52.6% | -39.1% | +7.8% | +2.5% | +47.3% |
| YoY Change | — | — | — | — | -7.0% | -11.0% | -9.4% | -9.6% | -11.8% | -8.4% | -8.9% | -1.3% | -7.3% | -3.5% | -3.9% | -5.3% | -1.0% | +2.0% | +2.7% | -0.9% |